Tyler Golato
Co-Initiator em VitaDAO · Partner em Triplicate · Co-Founder em Molecule · Co-Initiator em BIO Protocol
Tyler Golato é sócio da Triplicate e cofundador da Molecule, um protocolo de código aberto para desenvolvimento de medicamentos. Anteriormente, trabalhou no National Institute of Aging Research (NIH/NIA/IRP) sob a orientação do Dr. David M. Wilson III e do Dr. Vilhelm Bohr, focando no reparo de danos endógenos ao DNA, especialmente no contexto do envelhecimento. Além disso, Tyler cofundou a VitaDAO e a bio.xyz. Antes de trabalhar em DeSci, Tyler teve uma carreira inicial de sucesso como bioquímico, biólogo molecular e biogerontologista.
Funções atuais
Investimentos
Menções em notícias
May in the Biosphere 🌐 - PeptAI Ignition Sale: 32x+ oversubscribed, 1.6M+ USDC committed by 1.4K+ participants. veBIO staker reward claims now live in the Bio app. Next: first on-chain wet-lab attestation via Molecule Labs in Q2. - BIO on Robinhood: $BIO is now tradable on @RobinhoodApp, bringing
The chemical universe is too massive for brute-force computing. "It would take over 170 years to brute force this data set by running inference on every single possible molecule." @metanova_labs #SN68 "Nova blueprint" incentivizes global miners to design and open-source their algorithmic shortcut
hot take: a single water molecule isn't wet. but two are.
This AI Reads Your Chemistry Instructions and Finds the Best Way to Build You a Molecule
For a decade, AI, Web3, and Bio have scaled as parallel frontiers, but that era is ending.The defining companies of the
For a decade, AI, Blockchain, and Bio have scaled as parallel frontiers - but that era is ending.The defining companies
We're excited to announce The Convergence, YZi Labs' flagship conference of the year. On May 12 at the iconic Computer H
The scientist who would have studied your disease probably chose a different problem.
Most people describe biotech companies as a jump from discovery to application.
Prompt-to-DeFi Strategist Challenge: BNB Chain Edition